Literature DB >> 31538978

Extremity Cooling: A Synthesis of Cryotherapy Interventions to Reduce Peripheral Neuropathy and Nail Changes From Taxane-Based Chemotherapy.

Lauren Peyton1, Erica Fischer-Cartlidge1.   

Abstract

BACKGROUND: Taxane-based chemotherapies are frequently used to treat solid tumor cancers. Two significant side effects include nail changes and/or peripheral neuropathy. These side effects can cause pain, infections, dose reductions, and treatment delays, all of which negatively affect quality of life.
OBJECTIVES: This article synthesizes the literature on efficacy and tolerability of extremity cryotherapy during taxane administration to identify if it is an intervention that can be provided to patients to mitigate these symptoms.
METHODS: A literature review was performed using PubMed®, the Cochrane Database of Systematic Reviews, Ovid, Web of Science, and CINAHL®. 46 articles were initially identified, and 10 articles were reviewed (5 related to nail changes and 5 related to neuropathy).
FINDINGS: Larger, powered studies are needed on these topics; however, existing data suggest this intervention as a promising low-risk option for mitigating the severity of nail changes and peripheral neuropathy related to taxane chemotherapy.

Entities:  

Keywords:  cryotherapy; extremity cooling; nail changes; peripheral neuropathy; taxanes

Year:  2019        PMID: 31538978     DOI: 10.1188/19.CJON.522-528

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  1 in total

1.  An ex vivo organ culture screening model revealed that low temperature conditions prevent side effects of anticancer drugs.

Authors:  Tian Tian; Kanako Miyazaki; Yuta Chiba; Keita Funada; Tomomi Yuta; Kanji Mizuta; Yao Fu; Jumpei Kawahara; Xue Han; Yuna Ando; Ami Funada; Aya Yamada; Tsutomu Iwamoto; Seiji Nakamura; Ichiro Takahashi; Satoshi Fukumoto; Keigo Yoshizaki
Journal:  Sci Rep       Date:  2022-02-23       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.